// App-Quantinova.ai

142 : Can JAK 2 inhibitors improve UIP in rheumatoid arthritis patients? Food for thought!

Researchers

Presenter

  • Ganesh Kasavkar

Principal Investigators

  • Felix Woodhead

  • Joanna Shakespeare

  • Shirish Dubey

Medical Centers

  • Medical Oncology, University Hospital Coventry and Warwickshire, Coventry, UK

  • Respiratory Medicine, University Hospitals Leicester, Leicester, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Dyspnea

  • Inflammatory Arthritis

Biomarkers

  • Janus kinase

Drug/Treatment

  • Sulfasalazine

  • Methotrexate

  • Prednisolone

  • HWA-486

  • Adalimumab

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved